» Articles » PMID: 21346058

Evaluation of Widely Used Diagnostic Tests to Detect West Nile Virus Infections in Horses Previously Infected with St. Louis Encephalitis Virus or Dengue Virus Type 2

Overview
Date 2011 Feb 25
PMID 21346058
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Primary West Nile virus (WNV) infections can be diagnosed using a number of tests that detect infectious particles, nucleic acid, and specific IgM and/or IgG antibodies. However, serological identification of the infecting agent in secondary or subsequent flavivirus infections is problematic due to the extensive cross-reactivity of flavivirus antibodies. This is particularly difficult in the tropical Americas where multiple flaviviruses cocirculate. A study of sequential flavivirus infection in horses was undertaken using three medically important flaviviruses and five widely utilized diagnostic assays to determine if WNV infection in horses that had a previous St. Louis encephalitis virus (SLEV) or dengue virus type 2 (DENV-2) infection could be diagnosed. Following the primary inoculation, 25% (3/12) and 75% (3/4) of the horses mounted antibody responses against SLEV and DENV-2, respectively. Eighty-eight percent of horses subsequently inoculated with WNV had a WNV-specific antibody response that could be detected with one of these assays. The plaque reduction neutralization test (PRNT) was sensitive in detection but lacked specificity, especially following repeated flavivirus exposure. The WNV-specific IgM enzyme-linked immunosorbent assay (IgM ELISA) was able to detect an IgM antibody response and was not cross-reactive in a primary SLEV or DENV response. The WNV-specific blocking ELISA was specific, showing positives only following a WNV injection. Of great importance, we demonstrated that timing of sample collection and the need for multiple samples are important, as the infecting etiology could be misdiagnosed if only a single sample is tested.

Citing Articles

Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum.

Mashin V, Sergeev A, Martynova N, Sergeev A, Lysko K, Raikov A Pharm Chem J. 2022; 56(4):532-537.

PMID: 35845147 PMC: 9274627. DOI: 10.1007/s11094-022-02675-2.


Effect of Agroecosystems on Seroprevalence of St. Louis Encephalitis and West Nile Viruses in Birds, La Pampa, Argentina, 2017-2019.

Mansilla A, Grande J, Diaz A Emerg Infect Dis. 2022; 28(7):1393-1402.

PMID: 35731160 PMC: 9239869. DOI: 10.3201/eid2807.211485.


Serological Evidence of West Nile Virus Infection Among Humans, Horses, and Pigeons in Saudi Arabia.

Alkharsah K, Al-Afaleq A Infect Drug Resist. 2022; 14:5595-5601.

PMID: 34992386 PMC: 8711105. DOI: 10.2147/IDR.S348648.


Detection of Neutralizing Antibodies to Tembusu Virus: Implications for Infection and Immunity.

Lv J, Yang L, Qu S, Meng R, Li Q, Liu H Front Vet Sci. 2020; 6:442.

PMID: 31921903 PMC: 6914806. DOI: 10.3389/fvets.2019.00442.


Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic.

Thomm A, Schotthoefer A, Dupuis 2nd A, Kramer L, Frost H, Fritsche T mSphere. 2018; 3(1).

PMID: 29359181 PMC: 5760746. DOI: 10.1128/mSphere.00467-17.


References
1.
SATHER G, HAMMON W . Protection against St. Louis encephalitis and West Nile arboviruses by previous dengue virus (types 1-4) infection. Proc Soc Exp Biol Med. 1970; 135(2):573-8. DOI: 10.3181/00379727-135-35098a. View

2.
Martin D, Noga A, Kosoy O, Johnson A, Petersen L, Lanciotti R . Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile Virus and St. Louis Encephalitis virus infections during the 2002 West Nile Virus epidemic in the United States. Clin Diagn Lab Immunol. 2004; 11(6):1130-3. PMC: 524784. DOI: 10.1128/CDLI.11.6.1130-1133.2004. View

3.
Blitvich B, Bowen R, Marlenee N, Hall R, Bunning M, Beaty B . Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals. J Clin Microbiol. 2003; 41(6):2676-9. PMC: 156482. DOI: 10.1128/JCM.41.6.2676-2679.2003. View

4.
Johnson A, Cheshier R, Cosentino G, Masri H, Mock V, Oesterle R . Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. Clin Vaccine Immunol. 2007; 14(9):1084-93. PMC: 2043310. DOI: 10.1128/CVI.00115-07. View

5.
Bunning M, Bowen R, Cropp C, Sullivan K, Davis B, Komar N . Experimental infection of horses with West Nile virus. Emerg Infect Dis. 2002; 8(4):380-6. PMC: 3393377. DOI: 10.3201/eid0804.010239. View